CD133-positive cells

posted on March 1, 2008 - 10:21am
A European group of researchers successfully used a combination of genetic correction and stem cells to treat Duchenne muscular dystrophy (DMD) in mice with the disease. The compound they used for the genetic correction was developed by Judith van Deutekom, then at Leiden (Netherlands) University Medical Center, with MDA support. DMD results from the loss of the muscle protein dystrophin because...

New content is being added every day. Please check back again.